Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
      Description

      The purpose of this phase 2 study is to evaluate the efficacy and safety of NIR178 in combination with PDR001 in multiple solid tumors and diffuse large B-cell lymphoma (DLBCL) and further explore schedule variations of NIR178 to optimize immune activation through inhibition of A2aR.

      Conditions
      NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic CancerUrothelial CancerHead and Neck CancerDLBCL, Diffused Large B Cell LymphomaMSS, Microsatellite Stable Colon CancerTNBC, Triple Negative Breast CancerMelanomamCRPC, Metastatic Castration Resistant Prostate Cancer
      Talk to us